RhumbLine Advisers’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $757K | Buy |
276,401
+6,663
| +2% | +$21.1K | ﹤0.01% | 2353 |
|
|
2025
Q4 | $998K | Sell |
269,738
-7,753
| -3% | -$25.1K | ﹤0.01% | 2222 |
|
|
2025
Q3 | $735K | Buy |
277,491
+1,803
| +0.7% | +$3.49K | ﹤0.01% | 2435 |
|
|
2025
Q2 | $271K | Buy |
275,688
+39,658
| +17% | +$39.7K | ﹤0.01% | 3054 |
|
|
2025
Q1 | $340K | Sell |
236,030
-10,884
| -4% | -$20.1K | ﹤0.01% | 2819 |
|
|
2024
Q4 | $543K | Buy |
246,914
+3,824
| +2% | +$8.92K | ﹤0.01% | 2635 |
|
|
2024
Q3 | $401K | Sell |
243,090
-8,948
| -4% | -$18.1K | ﹤0.01% | 2855 |
|
|
2024
Q2 | $560K | Buy |
252,038
+248,254
| +6,561% | +$584K | ﹤0.01% | 2593 |
|
|
2024
Q1 | $10.1K | Hold |
3,784
| – | – | ﹤0.01% | 3871 |
|
|
2023
Q4 | $11.3K | Hold |
3,784
| – | – | ﹤0.01% | 3846 |
|
|
2023
Q3 | $3.71K | Sell |
3,784
-3,353
| -47% | -$4.85K | ﹤0.01% | 4031 |
|
|
2023
Q2 | $9.92K | Sell |
7,137
-92,514
| -93% | -$129K | ﹤0.01% | 3956 |
|
|
2023
Q1 | $158K | Buy |
99,651
+6,823
| +7% | +$35.2K | ﹤0.01% | 2787 |
|
|
2022
Q4 | $578K | Buy |
92,828
+7,216
| +8% | +$51.6K | ﹤0.01% | 2398 |
|
|
2022
Q3 | $574K | Buy |
85,612
+9,899
| +13% | +$68K | ﹤0.01% | 2427 |
|
|
2022
Q2 | $482K | Buy |
75,713
+21,996
| +41% | +$125K | ﹤0.01% | 2519 |
|
|
2022
Q1 | $249K | Buy |
53,717
+22,584
| +73% | +$96.9K | ﹤0.01% | 2700 |
|
|
2021
Q4 | $156K | Sell |
31,133
-479
| -2% | -$3.83K | ﹤0.01% | 2884 |
|
|
2021
Q3 | $381K | Sell |
31,612
-1,266
| -4% | -$18.4K | ﹤0.01% | 2673 |
|
|
2021
Q2 | $695K | Buy |
32,878
+807
| +3% | +$19.4K | ﹤0.01% | 2416 |
|
|
2021
Q1 | $900K | Sell |
32,071
-2,876
| -8% | -$84.8K | ﹤0.01% | 2228 |
|
|
2020
Q4 | $909K | Buy |
34,947
+948
| +3% | +$28.4K | ﹤0.01% | 2174 |
|
|
2020
Q3 | $1.26M | Sell |
33,999
-9,610
| -22% | -$381K | ﹤0.01% | 1902 |
|
|
2020
Q2 | $2.24M | Buy |
43,609
+5,462
| +14% | +$229K | ﹤0.01% | 1668 |
|
|
2020
Q1 | $1.2M | Sell |
38,147
-804
| -2% | -$42.4K | ﹤0.01% | 1797 |
|
|
2019
Q4 | $2.32M | Buy |
38,951
+2,834
| +8% | +$127K | ﹤0.01% | 1716 |
|
|
2019
Q3 | $1.32M | Buy |
36,117
+210
| +0.6% | +$8.32K | ﹤0.01% | 1913 |
|
|
2019
Q2 | $1.67M | Buy |
35,907
+4,680
| +15% | +$220K | ﹤0.01% | 1843 |
|
|
2019
Q1 | $1.25M | Sell |
31,227
-356
| -1% | -$16K | ﹤0.01% | 1931 |
|
|
2018
Q4 | $1.45M | Buy |
31,583
+9,836
| +45% | +$474K | ﹤0.01% | 1830 |
|
|
2018
Q3 | $965K | Sell |
21,747
-1,314
| -6% | -$60.3K | ﹤0.01% | 2019 |
|
|
2018
Q2 | $904K | Buy |
23,061
+5,867
| +34% | +$296K | ﹤0.01% | 2046 |
|
|
2018
Q1 | $1.24M | Sell |
17,194
-740
| -4% | -$54.3K | ﹤0.01% | 1838 |
|
|
2017
Q4 | $1.18M | Sell |
17,934
-2,566
| -13% | -$138K | ﹤0.01% | 1871 |
|
|
2017
Q3 | $1.03M | Buy |
20,500
+1,960
| +11% | +$94.5K | ﹤0.01% | 1958 |
|
|
2017
Q2 | $858K | Sell |
18,540
-640
| -3% | -$23.5K | ﹤0.01% | 2023 |
|
|
2017
Q1 | $677K | Buy |
19,180
+2,846
| +17% | +$65.2K | ﹤0.01% | 2124 |
|
|
2016
Q4 | $205K | Sell |
16,334
-1,002
| -6% | -$11.9K | ﹤0.01% | 2661 |
|
|
2016
Q3 | $240K | Buy |
17,336
+150
| +0.9% | +$1.7K | ﹤0.01% | 2589 |
|
|
2016
Q2 | $170K | Buy |
17,186
+3,657
| +27% | +$60.6K | ﹤0.01% | 2808 |
|
|
2016
Q1 | $229K | Buy |
13,529
+80
| +0.6% | +$1.29K | ﹤0.01% | 2670 |
|
|
2015
Q4 | $299K | Buy |
13,449
+1,375
| +11% | +$34.7K | ﹤0.01% | 2580 |
|
|
2015
Q3 | $285K | Buy |
12,074
+589
| +5% | +$37K | ﹤0.01% | 2579 |
|
|
2015
Q2 | $939K | Buy |
11,485
+6,195
| +117% | +$606K | ﹤0.01% | 1904 |
|
|
2015
Q1 | $490K | Buy |
+5,290
| New | +$341K | ﹤0.01% | 2314 |
|
Other funds holding ESPR
WA
TSC
O
VCM
